Document Detail


Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants.
MedLine Citation:
PMID:  20819898     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Low birth weight infants are at risk for iron deficiency (ID). Most LBW infants have marginally low birth weight (MLBW, 2000-2500 g) and it is not known whether they benefit from iron supplements. The objective of this trial was to study the effects of iron supplementation in MLBW infants. METHOD: In a randomized controlled trial, we assigned 285 healthy, MLBW infants to receive iron supplements at a dose of 0 (placebo), 1, or 2 mg/kg per day between 6 weeks and 6 months of age. Hemoglobin levels, ferritin levels, transferrin saturation, mean cell volume, and transferrin receptor levels were analyzed at 6 months. Growth and morbidity were monitored. RESULTS: Iron supplementation resulted in significant dose-dependent effects on hemoglobin and all iron status indicators at 6 months. The prevalence of ID at 6 months was 36% in the placebo group, 8.2% in the 1 mg/kg per day group, and 3.8% in the 2 mg/kg per day group (P<.001). The prevalence rates of ID anemia (IDA) were 9.9%, 2.7%, and 0%, respectively (P=.004). Among infants who were exclusively breastfed at 6 weeks, the prevalence of IDA was 18% in the placebo group. There were no significant differences between groups in growth or morbidity. CONCLUSIONS: MLBW infants have relatively high risks of ID and IDA, especially if they are breastfed. Iron supplementation at 2 mg/kg per day from 6 weeks to 6 months reduces this risk effectively, with no short-term adverse effects on morbidity or growth.
Authors:
Staffan Berglund; Björn Westrup; Magnus Domellöf
Related Documents :
19111318 - Iron supplementation of low-income infants: a randomized clinical trial of adherence wi...
11779098 - Effect of recombinant human erythropoietin administration on lipid peroxidation and ant...
11192518 - Short-term developmental outcome of iron prophylaxis in infants.
9433148 - Absorption of iron from grape-molasses and ferrous sulfate: a comparative study in norm...
9481078 - Digoxin-like immunoreactivity in early infantile death.
20853208 - Poverty and union formation among never-married single mothers in the netherlands, 1989...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2010-09-06
Journal Detail:
Title:  Pediatrics     Volume:  126     ISSN:  1098-4275     ISO Abbreviation:  Pediatrics     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-05     Completed Date:  2010-10-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e874-83     Citation Subset:  AIM; IM    
Affiliation:
Umeå University, Department of Clinical Sciences, Division of Pediatrics, SE-901 85 Umeå, Sweden.
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00558454
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anemia, Iron-Deficiency / prevention & control*
Breast Feeding
Double-Blind Method
Female
Ferrous Compounds / administration & dosage*,  adverse effects
Hemoglobins / analysis
Humans
Infant
Infant, Low Birth Weight*
Infant, Newborn
Infant, Premature
Iron / administration & dosage,  blood
Male
Transferrin / analysis
Chemical
Reg. No./Substance:
0/Ferrous Compounds; 0/Hemoglobins; 10030-90-7/ferrous succinate; 11096-37-0/Transferrin; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Clinical Report--Physicians' Roles in Coordinating Care of Hospitalized Children.
Next Document:  Policy Statement--Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia.